Your search for smoking cessation returned 82 results

Par’s generic version of Chantix is currently the only available one in the US.

The recalled lots of Chantix were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from May 2019 to September 2021.

To date, the Company has not received any reports of adverse events related to this recall.

N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.

Long-term use of a product containing N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.

The outpatient procedure provides noninvasive magnetic stimulation to areas of the brain known to be associated with addiction.

The FDA has granted Breakthrough Therapy designation to AXS-05 (Axsome Therapeutics) for the treatment of Alzheimer disease (AD) agitation.

Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.

Both stable current smokers and individuals who had quit exhibited significantly less anxiety but more depression.

The use of electrical stimulation devices (ESDs) to treat self-injurious or aggressive behavior has been banned by the Food and Drug Administration (FDA).